Immunological enhancement of primary tumor development and its prevention.
about
Harnessing B cells in immunotherapyThe roles of regulatory B cells in cancerBridging innate and adaptive antitumor immunity targeting glycans.Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells.IgG expression in human colorectal cancer and its relationship to cancer cell behaviors.Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.Polarized immune responses differentially regulate cancer development.Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma.Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients.B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice.Immunoglobulin expression in non-lymphoid lineage and neoplastic cells.Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinomaInteractions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunityEvaluation of humoral immunity in oral cancer patients from a nigerian referral centre.CD40-activated B cells contribute to mesothelioma tumor regression.B cells contribute to the antitumor activity of CpG-oligodeoxynucleotide in a mouse model of metastatic lung carcinoma.
P2860
Q28066838-244CA30A-DCAE-426B-B319-C1D937332296Q33765986-0E8EB90F-9CDF-4D23-BA94-B94258E8A7CAQ33960021-A3984F89-E13A-4BED-ABCD-8FFB09E3407BQ34341357-D16AA2A5-1B34-4BCD-9BA8-01A4DE2E29BAQ34469524-B4EE9280-1050-4178-947D-666B38B73907Q36393268-38C49B7F-A16B-4BFC-94B7-6F1D89CCB270Q36808629-DB115EB8-44A0-4916-BDE9-68D98AF3E0A5Q36868556-C04B5F1F-AC61-4796-A54F-894DA2405E2CQ36950893-B17A5515-A056-4B46-9F60-8B12ADDF4455Q37069120-06604AC9-5E25-4FAB-B543-E2B0DE755F21Q37402190-DE7FD14D-FACB-4010-BA10-8F4DA1157772Q37402456-7EB72AE8-E929-4FAD-A20B-AAF19E931FA3Q37734258-D7C6AAA1-CE4C-4E7B-A40E-DC88DA9B27D2Q41894093-EB513E3E-21F1-41F9-AABC-FBD7CADF6EC8Q43406455-5E781CB1-B690-441E-AF56-3D8089FDA563Q44945891-C97C2781-744B-498C-9BB7-73BF09B6064F
P2860
Immunological enhancement of primary tumor development and its prevention.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunological enhancement of primary tumor development and its prevention.
@ast
Immunological enhancement of primary tumor development and its prevention.
@en
Immunological enhancement of primary tumor development and its prevention.
@nl
type
label
Immunological enhancement of primary tumor development and its prevention.
@ast
Immunological enhancement of primary tumor development and its prevention.
@en
Immunological enhancement of primary tumor development and its prevention.
@nl
prefLabel
Immunological enhancement of primary tumor development and its prevention.
@ast
Immunological enhancement of primary tumor development and its prevention.
@en
Immunological enhancement of primary tumor development and its prevention.
@nl
P2093
P356
P1476
Immunological enhancement of primary tumor development and its prevention.
@en
P2093
P304
P356
10.1006/SCBI.2000.0331
P577
2000-10-01T00:00:00Z